May 19, 2017

Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study

May 15, 2017

Amicus Therapeutics Announces Positive Functional Data from Initial Patients in Pompe Phase 1/2 Study

May 10, 2017

Amicus Therapeutics to Present at Two Upcoming Investor Conferences